Skip to main content
. Author manuscript; available in PMC: 2018 Mar 30.
Published in final edited form as: Best Pract Res Clin Endocrinol Metab. 2017 Mar 30;31(2):183–194. doi: 10.1016/j.beem.2017.03.004

Fig. 1.

Fig. 1

Topology model of TSHR with location of confirmed or putative inactivating mutations identified in subjects with RTSH. Missense mutations are indicated in orange, nonsense mutations in red, insertions/deletions in the coding sequence in yellow, and intronic mutations in blue. Residues forming the beta strands of the leucine-rich repeats within the extracellular ligand-binding domain are marked by green arrows. SP, signal peptide sequence (removed in mature protein).